Privia Health Group Inc. (NASDAQ:PRVA) saw an upside of 0.16% to close Friday at $25.14 after adding $0.04 on the day. The 5-day average trading volume is 665,340 shares of the company’s common stock. It has gained $27.34 in the past week and touched a new high 2 times within the past 5 days. An average of 732,315 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,656,562.
PRVA’s 1-month performance is -6.51% or -$2.35 on its low of $24.70 reached on 08/18/23. The company’s shares have touched a 52-week low of $20.64 and high of $44.64, with the stock’s rally to the 52-week high happening on 05/09/23. YTD, PRVA has achieved 10.70% or $2.43 and has reached a new high 17 times. However, the current price is down -43.68% from the 52-week high price.
Insider Transactions
PRVA stock investors last saw insider trading activity on Aug 04.Sullivan William M (Director) most recently sold 18,153 shares at $27.10 per share on Aug 04. This transaction cost the insider $491,935. EVP, General Counsel, Bartrum Thomas, sold 15,000 shares at a price of $26.51 on Aug 03. Then, on Jul 31, Chief Executive Officer Mehrotra Parth sold 31,744 shares at a price of $28.03 per share. This transaction amounted to $889,784.
Valuation Metrics
PRVA stock has a beta of 0.83. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 1.95 while the price-to-book (PB) in the most recent quarter is 5.56, with the price to cash flow ratio at 74.77.
Privia Health Group Inc.’s quick ratio for the period ended June 29 was 1.80, with the current ratio over the same period at 1.80. In terms of profitability, the gross margin trailing 12 months is 10.00%. The trailing 12-month EBITDA margin is -1.07% while for the period ending June 29, Privia Health Group Inc.’s operating margin was 0.80%. The firm’s gross profit as reported stood at $134.78 million against revenue of $1.36 billion.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 244.15% to $7.27 million, while revenue of $7.32 million was -0.69% off the previous quarter. Analysts expected PRVA to announce $0.06 per share in earnings in its latest quarter, but it posted $0.06, representing a 0.00% surprise. EBITDA for the quarter stood at more than $8.67 million. PRVA stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 366.26 million, with total debt at $9.71 million. Shareholders hold equity totaling $117.36 million.
Let’s look briefly at Privia Health Group Inc. (PRVA) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 18 August was 31.24% to suggest the stock is trending Neutral, with historical volatility in this time period at 27.65%.
The stock’s 5-day moving average is $26.07, reflecting a -7.06% or -$1.91 change from its current price. PRVA is currently trading -7.13% above its 20-day SMA, -10.25% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -0.55% and SMA200 by-24.91%.
Stochastic %K and %D was 12.77% and 28.04% and the average true range (ATR) pointed at 0.93. The RSI (14) points at 38.93%, while the 14-day stochastic is at 13.33% with the period’s ATR at 0.97. The stock’s 9-day MACD Oscillator is pointing at -1.01 and -1.22 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Privia Health Group Inc. (NASDAQ: PRVA), Evercore ISI launched coverage with an Outperform rating. Analysts offering their rating for PRVA stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate PRVA as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 18 have offered a “buy” rating.
What is PRVA’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $31.50 and a high of $45.00, with their median price target at $36.00. Looking at these predictions, the average price target given by analysts is for Privia Health Group Inc. (PRVA) stock is $37.32.
